申请人:CAMBRIDGE ENTERPRISE LIMITED
公开号:US20170174644A1
公开(公告)日:2017-06-22
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer (such as a cancer characterised by low levels of LMNA expression).